For example, hepatocyte-derived DPP4 promotes visceral adipose tissue inflammation and insulin resistance in individuals with obesity26, and deletion of adipocyte-specific DPP4 expression protects against obesity-related metabolic dysfunction27. Here, DPP4 is linked to Insulin resistance.